AAAAAA

   
Results: 1-8 |
Results: 8
Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant
Authors: Akunne, HC Zoski, KT Whetzel, SZ Cordon, JJ Brandon, RM Roman, F Pugsley, TA
Citation: Hc. Akunne et al., Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant, NEUROPHARM, 41(1), 2001, pp. 138-149
PD 158771, a potential antipsychotic agent with D-2/D-3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects
Authors: Akunne, HC Zoski, KT Davis, MD Cooke, LW Meltzer, LT Whetzel, SZ Shih, YH Wustrow, DJ Wise, LD MacKenzie, RG Georgic, LM Heffner, TG Pugsley, TA
Citation: Hc. Akunne et al., PD 158771, a potential antipsychotic agent with D-2/D-3 partial agonist and 5-HT1A agonist actions. I. Neurochemical effects, NEUROPHARM, 39(7), 2000, pp. 1197-1210
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects
Authors: Corbin, AE Meltzer, LT Ninteman, FW Wiley, JN Cristoffersen, CL Wustrow, DJ Wise, LD Pugsley, TA Heffner, TG
Citation: Ae. Corbin et al., PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT1A agonist actions. II. Preclinical behavioral effects, NEUROPHARM, 39(7), 2000, pp. 1211-1221
Stimulus-dependent modulation of [H-3] norepinephrine release from rat neocortical slices by gabapentin and pregabalin
Authors: Dooley, DJ Donovan, CM Pugsley, TA
Citation: Dj. Dooley et al., Stimulus-dependent modulation of [H-3] norepinephrine release from rat neocortical slices by gabapentin and pregabalin, J PHARM EXP, 295(3), 2000, pp. 1086-1093
Thiazoloindans and thiazolobenzopyrans: A novel class of orally active central dopamine (partial) agonists
Authors: van Vliet, LA Rodenhuis, N Wikstrom, H Pugsley, TA Serpa, KA Meltzer, LT Heffner, TG Wise, LD Lajiness, ME Huff, RM Svensson, K Haenen, GRMM Bast, A
Citation: La. Van Vliet et al., Thiazoloindans and thiazolobenzopyrans: A novel class of orally active central dopamine (partial) agonists, J MED CHEM, 43(19), 2000, pp. 3549-3557
Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D-3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907)
Authors: van Vliet, LA Rodenhuis, N Dijkstra, D Wikstrom, H Pugsley, TA Serpa, KA Meltzer, LT Heffner, TG Wise, LD Lajiness, ME Huff, RM Svensson, K Sundell, S Lundmark, M
Citation: La. Van Vliet et al., Synthesis and pharmacological evaluation of thiopyran analogues of the dopamine D-3 receptor-selective agonist (4aR,10bR)-(+)-trans-3,4,4a,10b-tetrahydro-4-n-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol (PD 128907), J MED CHEM, 43(15), 2000, pp. 2871-2882
A series of 6-and 7-piperazinyl- and -piperidinylmethylbenzoxazinones withdopamine D4 antagonist activity: Discovery of a potential atypical antipsychotic agent
Authors: Belliotti, TR Wustrow, DJ Brink, WA Zoski, KT Shih, YH Whetzel, SZ Georgic, LM Corbin, AE Akunne, HC Heffner, TG Pugsley, TA Wise, LD
Citation: Tr. Belliotti et al., A series of 6-and 7-piperazinyl- and -piperidinylmethylbenzoxazinones withdopamine D4 antagonist activity: Discovery of a potential atypical antipsychotic agent, J MED CHEM, 42(25), 1999, pp. 5181-5187
Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists
Authors: Kesten, SR Heffner, TG Johnson, SJ Pugsley, TA Wright, JL Wise, LD
Citation: Sr. Kesten et al., Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists, J MED CHEM, 42(18), 1999, pp. 3718-3725
Risultati: 1-8 |